Press Release

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Cholera Vaccines Market to Grow at a CAGR of 8.6% During 2021-2026, Aided by the Rising Incidences of Cholera Worldwide

According to a new report by EMR titled, ‘Global Cholera Vaccines Market Report and Forecast 2021-2026’, the market attained a value of around USD 80 million in 2020. It is expected to witness a healthy growth in the forecast period, growing at a CAGR of 8.6% between 2021 and 2026 to reach USD 129.4 million by 2026.

The global cholera vaccines industry is being driven by the increasing incidences of cholera worldwide. This can be attributed to the lack of proper sanitation facilities, especially in the third world economies. In addition, increased investments by the government to support the pharmaceutical industry are also projected to aid the market growth. In addition, the growing focus of international organisations such as UNICEF and WHO in strategising initiatives to combat the spread of cholera is also inviting capital expenditure in the development of effective vaccines. These factors are anticipated to propel the market growth in the forecast period.

The increased demand for efficient cholera vaccines and the heightened capital expenditure by the leading market players and the governments in research and development of vaccines are predicted to aid the market growth. For instance, in January 2020, Emergent BioSolutions Inc. (NYSE: EBS) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) suggested a positive opinion for the approval of the company’s new single-dose oral cholera vaccine, Vaxchora and expected a near-term approval by the EMA, which would make Vaxchora the only single-dose oral vaccine for adults and children above 6 years, indicated for active immunisation against the disease caused by Vibrio cholerae serogroup O1. These developments are expected to positively impact the growth of the cholera vaccines industry in the forecast period.

Market Breakup by Product and Region:

  • The market is divided based on product into Dukoral, Shanchol, Vaxchora, and others.
  • Region-wise, the global market for cholera vaccines can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Key Findings of the Report:

  • The global market for cholera vaccines is being driven by the increased cases of cholera globally.
  • The increased expenditure by the governments and international organisations in the development of strategies to combat the spread of cholera has significantly contributed to the market expansion.
  • Rising awareness about cholera treatment and the growing vaccination drives are also aiding the industry growth.
  • The growing pharmaceutical industry is further propelling the market growth.

Key Offerings of the Report:

  • The EMR report gives an overview of the global market for cholera vaccines for the periods (2016-2020) and (2021-2026).
  • The report also offers historical (2016-2020) and forecast (2021-2026) market information for the products and regions of cholera vaccines.
  • The report analyses the market dynamics, covering the key demand and price indicators in the market, along with providing an assessment of the SWOT and Porter’s Five Forces models.

The major players in the global cholera vaccines market are Sanofi-aventis Groupe, Emergent BioSolutions Inc., Valneva SE, GlaxoSmithKline plc., Intervet Inc., EuBiologics Co., Ltd., and others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.

About Us:

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us:

Expert Market Research
Website: www.expertmarketresearch.com
Email: sales@expertmarketresearch.com
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER